Skip to main content
Clinical Trials/EUCTR2020-001530-35-ES
EUCTR2020-001530-35-ES
Active, not recruiting
Phase 1

Randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts. COVID-19

Fundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)0 sites450 target enrollmentApril 13, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Fundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)
Enrollment
450
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2020
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Fundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)

Eligibility Criteria

Inclusion Criteria

  • · Men and women aged between 18 and 65 years.
  • · They are part of the health personnel of public or private hospitals of the Spanish hospital network in an area with risk of transmission of SARS\-CoV\-2\.
  • · Not having been previously diagnosed with SARS\-CoV\-2 (COVID\-19\) infection.
  • · Have not exhibited symptoms consistent with SARS\-CoV\-2 (COVID\-19\) infection from March 1, 2020 until entry into the trial.
  • · Understand the purpose of the study and have NOT taken any medications such as PrEP against SARS\-CoV\-2 from March 1, 2020 until trial entry (also includes PrEP for HIV).
  • · Have a negative PCR for SARS\-CoV\-2 at the entrance.
  • Negative urine pregnancy test performed in the 7 days prior to the start of study treatment in pre\-menopausal women or \<2 years after menopause.
  • · Women of childbearing potential and men of childbearing potential should commit to using a highly effective method of contraception (such as surgical sterilization, double barrier method, oral contraceptives or hormonal contraceptive implants) and to continue using them until the day of the last dose. of treatment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:

Exclusion Criteria

  • HIV infection.
  • Active infection with hepatitis B virus.
  • Kidney failure (creatinine clearance \<60 ml / min / 1\.72 m2\) and participants on hemodialysis.
  • Osteoporosis.
  • Myasthenia gravis.
  • Pre\-existing maculopathy of the eye.
  • Retinitis pigmentosa.
  • Bradycardia \<50 beats / minute.
  • Weight \<40 Kg.
  • Participants with immunosuppressive or hematological disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma
EUCTR2015-001801-15-ESFIBICO
Active, not recruiting
Phase 1
Clinical Trial to evaluate the effectivity and efficiency of preemptive genotyping before treatment with voriconazoleInvasive fungal disease in the hematologic patient.MedDRA version: 20.0 Level: HLGT Classification code 10017528 Term: Fungal infectious disorders System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0 Level: HLT Classification code 10040054 Term: Sepsis, bacteraemia, viraemia and fungaemia NEC System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0 Level: HLT Classification code 10029355 Term: Neutropenias System Organ Class: 100000004851MedDRA version: 20.0 Level: LLT Classification code 10076734 Term: Chemotherapy induced neutropenia System Organ Class: 100000004851MedDRA version: 20.1 Level: PT Classification code 10061187 Term: Haematopoietic neoplasm System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10059041 Term: Allogeneic peripheral haematopoietic stem cell transplant System Organ Class: 100000004865MedDRA version: 20.0 Level: LLT Classification code 10059040 Term: Autologous peripheral haematopoietic stem cell transplant System Organ Class: 100000004865Therapeutic area: Body processes [G] - Microbiological Phenomena [G06]
EUCTR2019-000376-41-ESFundación de Investigación del Hospital Universitario La Paz (FIBHULP)146
Recruiting
Not Applicable
Multi-center randomized controlled trial to evaluate oral vitamin B12 treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patientsgastric cancer
JPRN-UMIN000030727yokohama city university160
Recruiting
Not Applicable
Multicenter Randomized Clinical Trial to Assess the Effect of Active versus Passive Recharge Burst Spinal Cord Stimulation on Pain Relief in Failed Back SurgeryChronische pijn veroorzaakt door failed back surgery syndrome.chronic low back painFailed back surgery syndrome
NL-OMON52034Rijnstate Ziekenhuis94
Completed
Not Applicable
Fitness for the Ageing Brain Study II
ACTRN12609000755235The University of Melbourne230